Acadia Healthcare (NASDAQ:ACHC) Price Target Raised to $24.00

Acadia Healthcare (NASDAQ:ACHC) had its price target increased by TD Cowen from $22.00 to $24.00 in a research report sent to investors on Thursday morning,Benzinga reports. TD Cowen currently has a buy rating on the stock.

A number of other equities analysts also recently commented on the company. Mizuho dropped their price objective on Acadia Healthcare from $22.00 to $17.00 and set a “neutral” rating on the stock in a report on Thursday, December 18th. Bank of America downgraded shares of Acadia Healthcare from a “neutral” rating to an “underperform” rating and decreased their target price for the stock from $21.50 to $13.00 in a research report on Wednesday, December 3rd. Royal Bank Of Canada raised their price target on shares of Acadia Healthcare from $17.00 to $28.00 and gave the company an “outperform” rating in a report on Thursday. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating for the company in a research note on Wednesday, December 3rd. Finally, Jefferies Financial Group downgraded shares of Acadia Healthcare to a “hold” rating in a research report on Thursday, January 22nd. Seven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $20.69.

Acadia Healthcare Trading Up 5.2%

NASDAQ ACHC opened at $23.44 on Thursday. The company has a current ratio of 1.55, a quick ratio of 1.44 and a debt-to-equity ratio of 1.27. Acadia Healthcare has a 1-year low of $11.43 and a 1-year high of $33.58. The firm’s fifty day simple moving average is $14.82 and its 200-day simple moving average is $18.56. The company has a market capitalization of $2.16 billion, a PE ratio of -1.92, a price-to-earnings-growth ratio of 8.06 and a beta of 0.89.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, February 25th. The company reported $0.07 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.04. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The firm had revenue of $821.46 million for the quarter, compared to the consensus estimate of $800.10 million. During the same quarter in the previous year, the company posted $0.64 earnings per share. The business’s quarterly revenue was up 6.1% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. As a group, sell-side analysts anticipate that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of ACHC. Allworth Financial LP grew its position in shares of Acadia Healthcare by 676.4% in the second quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after purchasing an additional 1,177 shares during the last quarter. EverSource Wealth Advisors LLC boosted its stake in Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after purchasing an additional 497 shares during the period. Wells Fargo & Company MN grew its holdings in Acadia Healthcare by 208.9% in the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after buying an additional 1,510 shares during the last quarter. Bayforest Capital Ltd acquired a new stake in Acadia Healthcare in the 4th quarter valued at approximately $52,000. Finally, Hantz Financial Services Inc. increased its position in Acadia Healthcare by 501.9% in the 3rd quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock worth $54,000 after buying an additional 1,822 shares during the period.

Trending Headlines about Acadia Healthcare

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Q4 revenue topped estimates and EPS beat consensus, driving a strong intraday jump; management provided FY2026 and Q1 2026 guidance that gave investors a clearer outlook. Acadia Healthcare’s (NASDAQ:ACHC) Q4 CY2025 Sales Top Estimates, Stock Jumps 10.8%
• Positive Sentiment: The company posted its Q4 earnings presentation and materials, helping investors parse revenue mix, margin drivers and the path to management’s FY26 targets. Acadia Healthcare Company, Inc. 2025 Q4 – Results – Earnings Call Presentation
• Positive Sentiment: Multiple brokerages raised price targets and maintain buy/outperform stances—RBC to $28 (outperform), UBS to $27 (buy) and TD Cowen to $24 (buy)—which increases buy-side conviction and likely supported the rally. Benzinga: Analyst Price-Target Updates
• Positive Sentiment: Analysts and commentary highlighted improving execution and embedded EBITDA opportunities under returning management, reinforcing the view that operational fixes could restore profitability. TipRanks: Buy Rating on Improving Execution
• Neutral Sentiment: Aggregated analyst coverage: a Benzinga deep-dive summarizes 17 analyst ratings and consensus perspectives — useful for context on how Street expectations are shifting but not a single catalyst. Acadia Healthcare Co Stock: A Deep Dive Into Analyst Perspectives (17 Ratings)
• Negative Sentiment: Short interest remains very large (~32.45M shares as of mid‑Feb, ~35.9% of float) with a ~7.3 days-to-cover ratio — this high short position increases the risk of volatile trading, squeezes, or pressure if execution disappoints. (short-interest reports summarized in filings and market data)

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.